NDRG1

N-myc downstream regulated 1, the group of NDRG family

Basic information

Region (hg38): 8:133237175-133302022

Previous symbols: [ "CAP43" ]

Links

ENSG00000104419NCBI:10397OMIM:605262HGNC:7679Uniprot:Q92597AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Charcot-Marie-Tooth disease type 4D (Supportive), mode of inheritance: AR
  • Charcot-Marie-Tooth disease type 4D (Strong), mode of inheritance: AR
  • Charcot-Marie-Tooth disease type 4D (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Charcot-Marie-Tooth disease, type 4DARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic; Musculoskeletal; Neurologic10831399; 22978647; 23163601; 24136616

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NDRG1 gene.

  • Charcot-Marie-Tooth disease type 4 (14 variants)
  • Charcot-Marie-Tooth disease type 4D (5 variants)
  • not provided (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDRG1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
181
clinvar
1
clinvar
182
missense
196
clinvar
196
nonsense
9
clinvar
1
clinvar
1
clinvar
11
start loss
1
clinvar
1
clinvar
2
frameshift
5
clinvar
1
clinvar
2
clinvar
8
inframe indel
10
clinvar
1
clinvar
11
splice donor/acceptor (+/-2bp)
3
clinvar
16
clinvar
1
clinvar
20
splice region
16
49
4
69
non coding
1
clinvar
34
clinvar
159
clinvar
67
clinvar
261
Total 18 18 244 343 68

Highest pathogenic variant AF is 0.00000657

Variants in NDRG1

This is a list of pathogenic ClinVar variants found in the NDRG1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-133237256-A-C Charcot-Marie-Tooth disease type 4D Likely benign (Apr 27, 2017)362008
8-133237257-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)909267
8-133237405-C-T Charcot-Marie-Tooth disease type 4D Likely benign (Jan 12, 2018)362009
8-133237517-G-T Charcot-Marie-Tooth disease type 4D Uncertain significance (Apr 20, 2018)909268
8-133237538-C-T Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)362010
8-133237539-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)909269
8-133237578-C-G Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)909270
8-133237579-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)909271
8-133237582-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)362011
8-133237584-A-G Charcot-Marie-Tooth disease type 4D Benign (Jan 12, 2018)362012
8-133237683-C-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)362013
8-133237699-C-G Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)911264
8-133237743-C-T Charcot-Marie-Tooth disease type 4D Benign (Jan 13, 2018)362014
8-133237922-A-G Charcot-Marie-Tooth disease type 4D Benign (Jan 13, 2018)362015
8-133238012-T-A Charcot-Marie-Tooth disease type 4D Benign (Jan 12, 2018)362016
8-133238024-C-T Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)911462
8-133238044-A-T Charcot-Marie-Tooth disease type 4D Benign (Jan 13, 2018)362017
8-133238087-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)911463
8-133238167-G-A Charcot-Marie-Tooth disease type 4D Benign (Jan 13, 2018)362018
8-133238187-C-T Charcot-Marie-Tooth disease type 4D Benign (Jan 13, 2018)362019
8-133238201-G-A Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)362020
8-133238225-A-G Charcot-Marie-Tooth disease type 4D Likely benign (Apr 27, 2017)362021
8-133238260-A-C Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 12, 2018)362022
8-133238353-C-T Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)908488
8-133238475-C-T Charcot-Marie-Tooth disease type 4D Uncertain significance (Jan 13, 2018)908489

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NDRG1protein_codingprotein_codingENST00000414097 1564852
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01130.9881257181291257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6512262550.8850.00001682579
Missense in Polyphen88109.670.802381081
Synonymous-0.6641101011.080.00000744763
Loss of Function3.14824.90.3220.00000127271

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.0001990.000198
East Asian0.0001090.000109
Finnish0.0007870.000647
European (Non-Finnish)0.00009670.0000791
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53- mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy. {ECO:0000269|PubMed:15247272, ECO:0000269|PubMed:15377670, ECO:0000269|PubMed:17786215, ECO:0000269|PubMed:9766676}.;
Disease
DISEASE: Charcot-Marie-Tooth disease 4D (CMT4D) [MIM:601455]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269|PubMed:10831399}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Androgen Receptor Network in Prostate Cancer;TP53 Regulates Transcription of Cell Death Genes;VEGFA-VEGFR2 Signaling Pathway;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Transcriptional Regulation by TP53;Direct p53 effectors;Validated targets of C-MYC transcriptional repression;HIF-1-alpha transcription factor network (Consensus)

Recessive Scores

pRec
0.381

Intolerance Scores

loftool
0.732
rvis_EVS
-0.27
rvis_percentile_EVS
34.71

Haploinsufficiency Scores

pHI
0.366
hipred
Y
hipred_score
0.554
ghis
0.508

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ndrg1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); muscle phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
ndrg1b
Affected structure
thymus
Phenotype tag
abnormal
Phenotype quality
decreased size

Gene ontology

Biological process
signal transduction;negative regulation of cell population proliferation;response to metal ion;DNA damage response, signal transduction by p53 class mediator;peripheral nervous system myelin maintenance;regulation of apoptotic process;mast cell activation;cellular response to hypoxia;postsynapse organization
Cellular component
nucleus;cytoplasm;centrosome;cytosol;microtubule;plasma membrane;cell-cell adherens junction;microtubule cytoskeleton;myelin sheath;perinuclear region of cytoplasm;recycling endosome membrane;extracellular exosome;glutamatergic synapse
Molecular function
protein binding;microtubule binding;Rab GTPase binding;gamma-tubulin binding;cadherin binding